Skip to main content
placeholder image

A multi-site, fixed dose, parallel arm, double-blind, placebo controlled, block randomised trial of the addition of infusional octreotide or placebo to regular ranitidine and dexamethasone for the evaluation of vomiting associated with bowel obstruction at the end of life.

Journal Article


Abstract


Publication Date


  • 2012

Citation


  • Currow, D. C., Clark, K., Cartmill, J., Pather, S., Plummer, J., Eckermann, S., . . . Quinn, S. (2012). A multi-site, fixed dose, parallel arm, double-blind, placebo controlled, block randomised trial of the addition of infusional octreotide or placebo to regular ranitidine and dexamethasone for the evaluation of vomiting associated with bowel obstruction at the end of life.. Journal of Clinical Oncology, 30(15_suppl), tps9153. doi:10.1200/jco.2012.30.15_suppl.tps9153

Web Of Science Accession Number


Start Page


  • tps9153

End Page


  • tps9153

Volume


  • 30

Issue


  • 15_suppl

Place Of Publication


Abstract


Publication Date


  • 2012

Citation


  • Currow, D. C., Clark, K., Cartmill, J., Pather, S., Plummer, J., Eckermann, S., . . . Quinn, S. (2012). A multi-site, fixed dose, parallel arm, double-blind, placebo controlled, block randomised trial of the addition of infusional octreotide or placebo to regular ranitidine and dexamethasone for the evaluation of vomiting associated with bowel obstruction at the end of life.. Journal of Clinical Oncology, 30(15_suppl), tps9153. doi:10.1200/jco.2012.30.15_suppl.tps9153

Web Of Science Accession Number


Start Page


  • tps9153

End Page


  • tps9153

Volume


  • 30

Issue


  • 15_suppl

Place Of Publication